Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Geneva, CHE
Chemin du Grand-Puits 42
1217 Meyrin
Geneva, CHE

People

Co-founder and CTO
CFO
COO
CFO
President and CEO
Vice President Clinical and Regulatory Affairs
Board Member
Board Member
Show All People

Funding

Tags

Endosense

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense’s TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. It has undergone considerable pre-clinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.

Recent Milestones

Videos

Screenshots

Endosense screenshot
Above: Endosense
Uploaded: 10/28/09

Sources

  1. Endosense, SA: Series B $36M (onbiovc.com) [edit]
  2. Endosense Raises $40.3M in Series C Funding (finsmes.com) [edit]
  3. Endosense Secures Additional $4.3M in Series C Financing (finsmes.com) [edit]
Edit This Page
Last Edited 9/26/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy